Hologic Inc. logo

Hologic Inc. (HOLX)

Market Closed
5 Dec, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
74. 97
+0.11
+0.15%
$
16.67B Market Cap
38.79 P/E Ratio
0% Div Yield
1,652,346 Volume
3.91 Eps
$ 74.86
Previous Close
Day Range
74.83 75.09
Year Range
51.9 80.31
Want to track HOLX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 59 days
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It

Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It

Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Zacks | 7 months ago
Hologic vs. MYGN: Which Molecular Diagnostics Player Has More Upside?

Hologic vs. MYGN: Which Molecular Diagnostics Player Has More Upside?

In recent times, investors have been increasingly drawn to companies operating in the molecular diagnostics space, a rapidly growing segment within the broader in-vitro diagnostics (IVD) market. According to Roots Analysis, the IVD market is projected to witness a 6.2% compound annual growth rate through 2035.

Zacks | 7 months ago
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know

Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know

Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks | 7 months ago
Hologic (HOLX) Advances While Market Declines: Some Information for Investors

Hologic (HOLX) Advances While Market Declines: Some Information for Investors

Hologic (HOLX) concluded the recent trading session at $61.27, signifying a +0.67% move from its prior day's close.

Zacks | 8 months ago
Hologic Brings in New Leadership: A Signal to Stay Put With the Stock?

Hologic Brings in New Leadership: A Signal to Stay Put With the Stock?

HOLX's diagnostics strength, robust international potential and new board addition support its "Hold" case. Yet, ongoing global uncertainties remain a drag.

Zacks | 8 months ago
Hologic (HOLX) Outperforms Broader Market: What You Need to Know

Hologic (HOLX) Outperforms Broader Market: What You Need to Know

Hologic (HOLX) reachead $61.77 at the closing of the latest trading day, reflecting a +0.73% change compared to its last close.

Zacks | 8 months ago
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It

Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It

Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks | 8 months ago
Hologic (HOLX) Advances But Underperforms Market: Key Facts

Hologic (HOLX) Advances But Underperforms Market: Key Facts

In the most recent trading session, Hologic (HOLX) closed at $61.89, indicating a +0.68% shift from the previous trading day.

Zacks | 8 months ago
New Product Launches to Support HOLX Stock Amid Macro Issues

New Product Launches to Support HOLX Stock Amid Macro Issues

Hologic's Surgical business has been driving strong broad-based performance by expanding access to technologies in new global markets.

Zacks | 8 months ago
HOLX Stock Down 24.7% in 6 Months: Time to Cut Losses or Buy the Dip?

HOLX Stock Down 24.7% in 6 Months: Time to Cut Losses or Buy the Dip?

As Hologic works through the changing macroeconomic and geopolitical landscape, its long-term potential makes it a solid hold.

Zacks | 8 months ago
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know

Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know

Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Zacks | 8 months ago
Why Is Hologic (HOLX) Down 4.5% Since Last Earnings Report?

Why Is Hologic (HOLX) Down 4.5% Since Last Earnings Report?

Hologic (HOLX) reported earnings 30 days ago. What's next for the stock?

Zacks | 9 months ago
Loading...
Load More